Pemetrexed (P) alone or in combination with platinum for malignant pleural mesothelioma (MPM): Efficacy and toxicity of the International Expanded Access Program (EAP) in Spanish patients (p)

T. Moran; J. González-Larriba; J. Montesinos; J. Delgado; B. Massutí; G. López-Vivanco; J. López-Picazo; A. Peiró; L. G. Paz-Ares; R. Rosell

doi:10.1200/jco.2008.26.15_suppl.19038

Pemetrexed (P) alone or in combination with platinum for malignant pleural mesothelioma (MPM): Efficacy and toxicity of the International Expanded Access Program (EAP) in Spanish patients (p)

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.19038 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 19038-19038

Author(s):

T. Moran ◽

J. González-Larriba ◽

J. Montesinos ◽

J. Delgado ◽

B. Massutí ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program

Download Full-text

Single-Agent Pemetrexed for Chemonaïve and Pretreated Patients with Malignant Pleural Mesothelioma: Results of an International Expanded Access Program

Journal of Thoracic Oncology ◽

10.1097/jto.0b013e31817c73ec ◽

2008 ◽

Vol 3 (7) ◽

pp. 764-771 ◽

Cited By ~ 32

Author(s):

Paul Taylor ◽

Bruno Castagneto ◽

Graham Dark ◽

Maurizio Marangolo ◽

Giorgio V. Scagliotti ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Single Agent ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Pretreated Patients ◽

Access Program

Download Full-text

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7195 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7195-7195

Author(s):

M. Orlando ◽

A. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽

Access Program

Download Full-text

Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Access Program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7192 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7192-7192 ◽

Cited By ~ 1

Author(s):

A. J. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

H. Ross ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program

Download Full-text

Pemetrexed Alone or in Combination with Cisplatin in Previously Treated Malignant Pleural Mesothelioma: Outcomes from a Phase IIIB Expanded Access Program

Journal of Thoracic Oncology ◽

10.1097/01243894-200607000-00002 ◽

2006 ◽

Vol 1 (6) ◽

pp. 506-512 ◽

Cited By ~ 34

Author(s):

Pasi A. Jänne ◽

Antoinette J. Wozniak ◽

Chandra P. Belani ◽

Mary-Louise Keohan ◽

Helen J. Ross ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Phase Iiib ◽

Previously Treated ◽

Access Program

Download Full-text

Single-arm, open label study of pemetrexed plus cisplatin in chemotherapy naïve patients with malignant pleural mesothelioma: Outcomes of an expanded access program

Lung Cancer ◽

10.1016/j.lungcan.2006.09.023 ◽

2007 ◽

Vol 55 (2) ◽

pp. 187-194 ◽

Cited By ~ 20

Author(s):

Coleman K. Obasaju ◽

Zhishen Ye ◽

Antoinette J. Wozniak ◽

Chandra P. Belani ◽

Mary-Louise Keohan ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program

Download Full-text

Pemetrexed alone or in combination with cisplatin in previously treated patients with malignant pleural mesothelioma (MPM): Outcomes of an expanded access program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.7195 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7195-7195 ◽

Cited By ~ 1

Author(s):

M. Orlando ◽

A. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽

Access Program

Download Full-text

Pemetrexed in combination with cisplatin in the treatment of chemonaive patients with malignant pleural mesothelioma (MPM): Outcomes on Expanded Access Program (EAP)

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.7192 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 7192-7192

Author(s):

A. J. Wozniak ◽

P. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

H. Ross ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program

Download Full-text

OA09.06 Nivolumab in Recurrent Malignant Pleural Mesothelioma: Real-World Data From Expanded Access Program In The Netherlands

Journal of Thoracic Oncology ◽

10.1016/j.jtho.2021.01.308 ◽

2021 ◽

Vol 16 (3) ◽

pp. S123

Author(s):

R. Belderbos ◽

L. Cantini ◽

C. Gooijer ◽

D. Dumoulin ◽

R. Cornelissen ◽

...

Keyword(s):

The Netherlands ◽

Malignant Pleural Mesothelioma ◽

Real World ◽

Pleural Mesothelioma ◽

Real World Data ◽

World Data ◽

Expanded Access ◽

Expanded Access Program ◽

Access Program

Download Full-text

C5-03: Open-label study of pemetrexed alone or in combination with a platinum for previously treated patients (pts) with malignant pleural mesothelioma (MPM): Outcomes from the International Expanded Access Program (EAP)

Journal of Thoracic Oncology ◽

10.1097/01.jto.0000283218.40896.16 ◽

2007 ◽

Vol 2 (8) ◽

pp. S372-S373 ◽

Cited By ~ 5

Author(s):

Ulrich Gatzemeier ◽

Paul Taylor ◽

Joachim von Pawel ◽

Bruno Castagneto ◽

Graham Dark ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽

Access Program

Download Full-text

Survival update of a subset of previously treated patients with malignant pleural mesothelioma (MPM) in an expanded access program (eap) of pemetrexed (P) alone or combined with cisplatin (cis)

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.7173 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 7173-7173

Author(s):

M. Orlando ◽

T. F. Wozniak ◽

P. A. Janne ◽

C. P. Belani ◽

M. L. Keohan ◽

...

Keyword(s):

Malignant Pleural Mesothelioma ◽

Pleural Mesothelioma ◽

Expanded Access ◽

Expanded Access Program ◽

Previously Treated Patients ◽

Previously Treated ◽

Access Program

Download Full-text